Literature DB >> 23245237

Analysis of abiraterone stress degradation behavior using liquid chromatography coupled to ultraviolet detection and electrospray ionization mass spectrometry.

Alaa Khedr1, Ibrahim Darwish, Faida Bamane.   

Abstract

A validated stability-indicating LC-UV-ESI-MS analytical method was established to analyze abiraterone (ABR) and its potential degradation products (DPs) and was performed according to ICH guidelines. Trace amounts of DPs that might be released under different environmental conditions were determined. Stress conditions, including the effect of heat, acid-base hydrolysis, oxidation and UV-light were investigated. ABR was found to be sensitive to UV light and oxidation. Five potential mono-oxygenated ABR products were generated upon exposure to UV-irradiation. Di-, tri-, and tetra-oxygenated ABR were detected and progressively increased in quantity upon longer exposure to UV light. The ESI-MS response factors (RF) of potential DPs and ABR were not comparable. The ESI-MS response factor of each single potential degradation product was derived from the LC-UV analysis of concentrated solutions of pure and degraded ABR. The ESI-MS limit of detection (LOD) and limit of quantification (LOQ) of ABR were 30 and 80 pg/μL, respectively. The intra-day RSD was 0.20%, and the inter-day RSD was 0.30%.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23245237     DOI: 10.1016/j.jpba.2012.09.024

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  4 in total

1.  β-Cyclodextrin sensitized spectrofluorimetry for the determination of abiraterone acetate and abiraterone.

Authors:  Aiqin Gong; Xiashi Zhu
Journal:  J Fluoresc       Date:  2013-07-10       Impact factor: 2.217

2.  AQbD Driven Development of an RP-HPLC Method for the Quantitation of Abiraterone Acetate for its Pharmaceutical Formulations in the Presence of Degradants.

Authors:  Bikash Ranjan Jena; Siva Prasad Panda; Umasankar Kulandaivelu; Rajasekhar Reddy Alavala; G S N Koteswara Rao; Suryakanta Swain; Gurudutta Pattnaik; Debashish Ghose
Journal:  Turk J Pharm Sci       Date:  2021-12-31

3.  Biotransformation of Abiraterone Into Five Characteristic Metabolites by the Rat Gut Microbiota and Liver Microsomes.

Authors:  Adili Keranmu; Fei-Ya Yang; Wasilijiang Wahafu; Su-Jun Han; Guo-Sheng Yang; Nian-Zeng Xing
Journal:  Front Oncol       Date:  2022-07-22       Impact factor: 5.738

4.  Improved Dissolution and Pharmacokinetics of Abiraterone through KinetiSol® Enabled Amorphous Solid Dispersions.

Authors:  Urvi Gala; Dave Miller; Robert O Williams
Journal:  Pharmaceutics       Date:  2020-04-14       Impact factor: 6.321

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.